An FDA-approved synthetic THC significantly reduces agitation in Alzheimer's patients, improving treatment outcomes and ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

“Agitation is one of the most distressing symptoms of Alzheimer’s dementia, and we are pleased to make positive strides forward in treatment of these patients.” Alzheimer’s disease is the ...

Treatments currently available in the UK for Alzheimer’s disease focus mainly on controlling symptoms for people with mild to moderate disease, says Dr Athwal, adding there are currently no treatments ...

"It is the agitation, not the memory loss, that often drives individuals with dementia to the emergency ... needed to better understand predictors of treatment response to help inform subsequent ...